specialty pharmaceuticals

CVS Health Enters Biosimilars Market With New Subsidiary Cordavis

CVS Health Enters Biosimilars Market With New Subsidiary Cordavis
CVS Health Enters Biosimilars Market With New Subsidiary Cordavis
August 23, 2023  |  Healthcare

CVS Health has launched Cordavis, a new subsidiary focused on bringing high-quality biosimilar products to the market to reduce drug costs. Get the Full Story Complete...

READ MORE >